Dashboard
Manage Tickers

VRNAVerona Pharma plc

Nasdaq veronapharma.com


$ 29.51 $ -0.78 (-2.58 %)    

Tuesday, 17-Sep-2024 14:07:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.26 $ -2.71 (-0.57 %)
DIA $ 417.43 $ -0.56 (-0.13 %)
SPY $ 562.92 $ -2.21 (-0.39 %)
TLT $ 100.86 $ -0.53 (-0.52 %)
GLD $ 237.43 $ -0.54 (-0.23 %)
$ 30.16
$ 30.29
$ 29.44 x 100
$ 29.56 x 100
$ 29.44 - $ 30.44
$ 11.39 - $ 30.73
668,605
na
2.45B
$ 1.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-07-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-03-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-verona-pharma-maintains-36-price-target
HC Wainwright & Co. Reiterates Buy on Vero...
09/17/2024 15:38:21

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $36 price...

verona-pharma-and-ritedose-partner-to-deliver-first-in-class-copd-drug-ohtuvayre
Verona Pharma And Ritedose Partner To Deli...
09/17/2024 12:31:11

-Ritedose is the development partner and manufacturer of Ohtuvayre (ensifentrine)*, the first inhaled product with a novel mech...

Core News & Articles
Petco, AppLovin, Dave & Buster's And Other...
09/11/2024 14:19:58

hc-wainwright--co-reiterates-buy-on-verona-pharma-maintains-36-price-target
HC Wainwright & Co. Reiterates Buy on Vero...
09/11/2024 11:36:07

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $36 price...

gsks-asthma-drug-meets-main-goal-in-phase-3-study-in-patients-with-smokers-lungs-prepares-competition-with-amgenastrazenecas-drug
GSK's Asthma Drug Meets Main Goal In Phase...
09/06/2024 10:56:44

GSK's Phase 3 MATINEE trial of Nucala in COPD met the primary endpoint, reducing exacerbations significantly over 104 weeks.

verona-pharma-to-present-oral-presentation-and-3-posters-on-additional-analyses-from-phase-3-enhance-copd-studies-at-ers-international-congress-2024
Verona Pharma To Present Oral Presentation...
09/05/2024 06:16:44

top-3-health-care-stocks-that-may-crash-in-august
Top 3 Health Care Stocks That May Crash In...
08/14/2024 12:35:02

9-health-care-stocks-whale-activity-in-todays-session
9 Health Care Stocks Whale Activity In Tod...
08/13/2024 17:35:23

verona-pharma-q2-2024-gaap-eps-011-beats-038-estimate-cash-position-4046m
Verona Pharma Q2 2024 GAAP EPS $(0.11) Bea...
08/08/2024 06:06:28

Verona Pharma (NASDAQ:VRNA) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.38)...

top-3-health-care-stocks-you-may-want-to-dump-this-quarter
Top 3 Health Care Stocks You May Want To D...
07/30/2024 14:13:47

canaccord-genuity-maintains-buy-on-verona-pharma-raises-price-target-to-37
Canaccord Genuity Maintains Buy on Verona ...
07/22/2024 12:34:20

Canaccord Genuity analyst Edward Nash maintains Verona Pharma (NASDAQ:VRNA) with a Buy and raises the price target from $35 ...

hc-wainwright--co-reiterates-buy-on-verona-pharma-maintains-36-price-target
HC Wainwright & Co. Reiterates Buy on Vero...
07/01/2024 11:01:42

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $36 price...

truist-securities-maintains-buy-on-verona-pharma-raises-price-target-to-38
Truist Securities Maintains Buy on Verona ...
06/28/2024 16:02:40

Truist Securities analyst Joon Lee maintains Verona Pharma (NASDAQ:VRNA) with a Buy and raises the price target from $32 to ...

first-inhaled-copd-therapy-in-over-2-decades---fda-approves-verona-pharmas-first-commercial-product
First Inhaled COPD Therapy In Over 2 Decad...
06/27/2024 13:49:19

The FDA has approved Verona Pharma's Ohtuvayre (ensifentrine) as maintenance treatment of chronic obstructive pulmonary dis...

canaccord-genuity-maintains-buy-on-verona-pharma-maintains-35-price-target
Canaccord Genuity Maintains Buy on Verona ...
06/27/2024 13:45:19

Canaccord Genuity analyst Edward Nash maintains Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $35 price target.

hc-wainwright--co-maintains-buy-on-verona-pharma-raises-price-target-to-36
HC Wainwright & Co. Maintains Buy on Veron...
06/27/2024 10:24:27

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Verona Pharma (NASDAQ:VRNA) with a Buy and raises the price tar...

trading-halt-halt-status-updated-at-52500-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 5:25:...
06/26/2024 21:25:06

verona-pharma-says-fda-approved-ohtuvayre-ensifentrine-for-maintenance-treatment-of-chronic-obstructive-pulmonary-disease-in-adult-patients
Verona Pharma Says FDA Approved Ohtuvayre ...
06/26/2024 20:59:51

Ohtuvayre is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more...

trading-halt-halted-at-45721-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 4:57:21 p.m. ET - ...
06/26/2024 20:57:25

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/25/2024 17:35:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION